The World Health Organization guideline recommends informing children of their HIV status
between the ages of 6–12 years. Primary caregivers of perinatal HIV-infected Thai …

With the advent of highly active antiretroviral therapy (HAART) HIV-infected children are
surviving into adulthood. Despite emerging evidence of the benefits of disclosure, when and …

Background As antiretroviral therapy (ART) allows the world's 2.3 million human
immunodeficiency virus (HIV)–infected children to grow and thrive, these children need to be …

Since the introduction of highly active antiretroviral therapy (ART) in 1996, HIV-infected
children often survive beyond adolescence. To assess worldwide trends in disclosure since …

While disclosure of HIV status to perinatally HIV-infected children has become an
increasingly important clinical issue, specific disclosure guidelines are lacking. We …

How and when to disclose a positive HIV diagnosis to an infected child is a complex
challenge for caregivers and healthcare workers. With the introduction of antiretroviral …

The study examined the patterns of disclosing the HIV diagnosis to infected children and
family members, and determined the demographic characteristics associated with …

Disclosure of HIV status to children and adolescents living with HIV remains a challenge in
pediatric HIV care. Many of the current disclosure guidelines from national and international …

Disclosure to HIV-infected children regarding their diagnosis is important as expanding
numbers of HIV-infected children attain adolescence and may become sexually active. In …

A provider-assisted, counselling-based, paediatric HIV disclosure model was developed
and implemented at two tertiary-care hospitals in Bangkok, Thailand. All undisclosed …